Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity

Journal of General Virology

Volumn 89, Issue 10, 2008, Pages 2518-2530

  Arita, Minetaro ^a   Wakita, Takaji ^a   Shimizu, Hiroyuki ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3,5 DIBROMO 4 HYDROXYBENZYLIDENE) 1,3 DIHYDRO 5 IODO 2 INDOLONE; 3 (3,5 DIBROMO 4 HYDROXYBENZYLIDINE 5 IODO 1,3 DIHYDROINDOL 2 ONE); 4,4',4'',4''' [CARBONYLBIS[IMINO 5,1,3,BENZENETRIYLBIS(CARBONYLIMINO)]]TETRAKIS(BENZENE 1,3 DISULFONIC ACID) OCTASODIUM SALT; 6 N BENZYLADENOSINE; ACTIVATING TRANSCRIPTION FACTOR 3; ANTIVIRUS AGENT; B RAF KINASE; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; MESSENGER RNA; METRIFUDIL; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN KINASE; PROTEIN KINASE GAK; PROTEIN KINASE MST2; PROTEIN KINASE PIM 1; PROTEIN KINASE PIM 2; PROTEIN KINASE PIM 3; PROTEIN OAS1; RAF PROTEIN; SMALL INTERFERING RNA; STAT1 PROTEIN; UNCLASSIFIED DRUG; 4,4,',4'',4''' (CARBONYLBIS(IMINO 5,1,3 BENZENETRIYLBIS(CARBONYLIMINO)))TETRAKIS(BENZENE 1,3 DISULFONATE); 4,4,',4'',4'''-(CARBONYLBIS(IMINO-5,1,3-BENZENETRIYLBIS(CARBONYLIMINO)))TETRAKIS(BENZENE-1,3-DISULFONATE); 5 IODO 3 ((3,5 DIBROMO 4 HYDROXYPHENYL)METHYLENE) 2 INDOLINONE; 5-IODO-3-((3,5-DIBROMO-4-HYDROXYPHENYL)METHYLENE)-2-INDOLINONE; ADENOSINE; BENZENESULFONIC ACID DERIVATIVE; CAPSID PROTEIN; DRUG DERIVATIVE; INDOLE DERIVATIVE; LUCIFERASE; N(6) BENZYLADENOSINE; N(6)-BENZYLADENOSINE; PHENOL DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG SCREENING; ENTEROVIRUS 71; HUMAN; HUMAN CELL; IC 50; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; SENDAI VIRUS; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; ANTIVIRAL RESISTANCE; CELL LINE; CHEMISTRY; DRUG EFFECT; ENTEROVIRUS; GENETICS; METABOLISM; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MOUSE; MUTATION; PATHOGENICITY; RNA INTERFERENCE;

HUMAN ENTEROVIRUS 71; POLIOVIRUS; SENDAI VIRUS;

ADENOSINE; ANIMALS; ANTIVIRAL AGENTS; BENZENESULFONATES; CAPSID PROTEINS; CELL LINE; DRUG RESISTANCE, VIRAL; ENTEROVIRUS; HUMANS; INDOLES; LUCIFERASES; MICE; MICROBIAL SENSITIVITY TESTS; MUTATION; PHENOLS; POLIOVIRUS; REPLICON; RNA INTERFERENCE; VIRUS REPLICATION;

EID: 54449087537     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.2008/002915-0     Document Type: Article

References (75)

1. Abdel-Rahman, S. M. & Kearns, G. L. (1998). Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution and effect of food. Antimicrob Agents Chemother 42, 2706-2709.
2. Arita, M., Nagata, N., Sata, T., Miyamura, T. & Shimizu, H. (2006). Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon. J Gen Virol 87, 3317-3327.
3. Arita, M., Nagata, N., Iwata, N., Ami, Y., Suzaki, Y., Mizuta, K., Iwasaki, T., Sata, T., Wakita, T. & Shimizu, H. (2007). An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol 81, 9386-9395.
4. Arita, M., Ami, Y., Wakita, T. & Shimizu, H. (2008). Cooperative effect of the attenuation determinants derived from poliovirus Sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol 82, 1787-1797.
5. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, J., McLauchlan, H., Klevernic, I., Arthur, S., Alessi, D. & Cohen, P. (2007). The selectivity of protein kinase inhibitors: a further update. Biochem J 408, 297-315.
6. Bedard, K. M., Daijogo, S. & Semler, B. L. (2007). A nucleocytoplasmic SR protein functions in viral IRES-mediated translation initiation. EMBO J 26, 459-467.
7. Belov, G. A., Habbersett, C., Franco, D. & Ehrenfeld, E. (2007). Activation of cellular Arf GTPases by poliovirus protein 3CD correlates with virus replication. J Virol 81, 9259-9267.
8. Blondel, B., Crainic, R., Fichot, O., Dufraisse, G., Candrea, A., Diamond, D., Girard, M. & Horaud, F. (1986). Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. J Virol 57, 81-90.
9. Bodian, D. (1949). Histopathologic basis of clinical findings in poliomyelitis. Am J Med 6, 563-578.
10. Bubeck, D., Filman, D. J. & Hogle, J. M. (2005). Cryo-electron microscopy reconstruction of a poliovirus-receptor-membrane complex. Nat Struct Mol Biol 12, 615-618.
11. Chang, L. Y., Lin, T. Y., Hsu, K. H., Huang, Y. C., Lin, K. L., Hsueh, C., Shih, S. R., Ning, H. C., Hwang, M. S. & other authors (1999). Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354, 1682-1686.
12. Chen, H. F., Chang, M. H., Chiang, B. L. & Jeng, S. T. (2006). Oral immunization of mice using transgenic tomato fruit expressing protein VP1 from enterovirus 71. Vaccine 24, 2944-2951.
13. Chen, H. M., Wang, L. & D'Mello, S. R. (2008). Inhibition of ATF-3 expression by B-Raf mediates the neuroprotective action of GW5074. J Neurochem 105, 1300-1312.
14. Chiu, C. H., Chu, C., He, C. C. & Lin, T. Y. (2006). Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect 8, 1671-1678.
15. Chumakov,M., Voroshilova, M., Shindarov, L., Lavrova, I., Gracheva, L., Koroleva, G., Vasilenko, S., Brodvarova, I., Nikolova, M. & other authors (1979). Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol 60, 329-340.
16. Crotty, S., Cameron, C. E. & Andino, R. (2001). RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 98, 6895-6900.
17. Crotty, S., Hix, L., Sigal, L. J. & Andino, R. (2002). Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection. J Gen Virol 83, 1707-1720.
18. Crotty, S., Saleh, M. C., Gitlin, L., Beske, O. & Andino, R. (2004). The poliovirus replication machinery can escape inhibition by an antiviral drug that targets a host cell protein. J Virol 78, 3378-3386.
19. de la Torre, J. C., Giachetti, C., Semler, B. L. & Holland, J. J. (1992). High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc Natl Acad Sci U S A 89, 2531-2535.
20. Diamond, D. C., Jameson, B. A., Bonin, J., Kohara, M., Abe, S., Itoh, H., Komatsu, T., Arita, M., Kuge, S. & other authors (1985). Antigenic variation and resistance to neutralization in poliovirus type 1. Science 229, 1090-1093.
21. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K. & Tuschl, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
22. Esfandiarei, M., Luo, H., Yanagawa, B., Suarez, A., Dabiri, D., Zhang, J. & McManus, B. M. (2004). Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent. J Virol 78, 4289-4298.
23. Geller, R., Vignuzzi, M., Andino, R. & Frydman, J. (2007). Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev 21, 195-205.
24. Gradi, A., Svitkin, Y. V., Imataka, H. & Sonenberg, N. (1998). Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc Natl Acad Sci U S A 95, 11089-11094.
25. Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36, 59-74.
26. Hasan, M. K., Kato, A., Shioda, T., Sakai, Y., Yu, D. & Nagai, Y. (1997). Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. J Gen Virol 78, 2813-2820.
27. Hellen, C. U., Witherell, G. W., Schmid, M., Shin, S. H., Pestova, T. V., Gil, A. & Wimmer, E. (1993). A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc Natl Acad Sci U S A 90, 7642-7646.
28. Ho, M., Chen, E. R., Hsu, K. H., Twu, S. J., Chen, K. T., Tsai, S. F., Wang, J. R. & Shih, S. R. (1999). An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med 341, 929-935.
29. Huang, C. C., Liu, C. C., Chang, Y. C., Chen, C. Y., Wang, S. T. & Yeh, T. F. (1999). Neurologic complications in children with enterovirus 71 infection. N Engl J Med 341, 936-942.
30. Hunt, S. L., Hsuan, J. J., Totty, N. & Jackson, R. J. (1999). unr, a cellular cytoplasmic RNA-binding protein with five cold-shock domains, is required for internal initiation of translation of human rhinovirus RNA. Genes Dev 13, 437-448.
31. Ida-Hosonuma, M., Iwasaki, T., Taya, C., Sato, Y., Li, J., Nagata, N., Yonekawa, H. & Koike, S. (2002). Comparison of neuropathogenicity of poliovirus in two transgenic mouse strains expressing human poliovirus receptor with different distribution patterns. J Gen Virol 83, 1095-1105.
32. Irurzun, A., Perez, L. & Carrasco, L. (1992). Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A. Virology 191, 166-175.
33. Kaärber, G. (1931). Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn Schmiedebergs Arch Pharmacol 162, 480-483.
34. Koike, S., Taya, C., Aoki, J., Matsuda, Y., Ise, I., Takeda, H., Matsuzaki, T., Amanuma, H., Yonekawa, H. & Nomoto, A. (1994). Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene - influence of the transgene expression on pathogenesis. Arch Virol 139, 351-363.
35. Komatsu, H., Shimizu, Y., Takeuchi, Y., Ishiko, H. & Takada, H. (1999). Outbreak of severe neurologic involvement associated with enterovirus 71 infection. Pediatr Neurol 20, 17-23.
36. Krausslich, H. G., Nicklin, M. J., Toyoda, H., Etchison, D. & Wimmer, E. (1987). Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol 61, 2711-2718.
37. Lackey, K., Cory, M., Davis, R., Frye, S. V., Harris, P. A., Hunter, R. N., Jung, D. K., McDonald, O. B., McNutt, R. W. & other authors (2000). The discovery of potent cRaf1 kinase inhibitors. Bioorg Med Chem Lett 10, 223-226.
38. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
39. Liu, M. L., Lee, Y. P., Wang, Y. F., Lei, H. Y., Liu, C. C., Wang, S. M., Su, I. J., Wang, J. R., Yeh, T. M. & other authors (2005). Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 86, 3263-3269.
40. Liu, C. C., Lian, W. C., Butler, M. & Wu, S. C. (2007). High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine 25, 19-24.
41. Lum, L. C., Wong, K. T., Lam, S. K., Chua, K. B., Goh, A. Y., Lim, W. L., Ong, B. B., Paul, G., AbuBakar, S. & Lambert, M. (1998). Fatal enterovirus 71 encephalomyelitis. J Pediatr 133, 795-798.
42. Luo, H., Yanagawa, B., Zhang, J., Luo, Z., Zhang, M., Esfandiarei, M., Carthy, C., Wilson, J. E., Yang, D. & McManus, B. M. (2002). Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol 76, 3365-3373.
43. Macejak, D. G. & Sarnow, P. (1992). Association of heat shock protein 70 with enterovirus capsid precursor P1 in infected human cells. J Virol 66, 1520-1527.
44. MacLennan, C., Dunn, G., Huissoon, A. P., Kumararatne, D. S., Martin, J., O'Leary, P., Thompson, R. A., Osman, H., Wood, P. & other authors (2004). Failure to clear persistent vaccine-derived neuro-virulent poliovirus infection in an immunodeficient man. Lancet 363, 1509-1513.
45. Maynell, L. A., Kirkegaard, K. & Klymkowsky, M. W. (1992). Inhibition of poliovirus RNA synthesis by brefeldin A. J Virol 66, 1985-1994.
46. McMinn, P. C. (2002). An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26, 91-107.
47. Meerovitch, K., Svitkin, Y. V., Lee, H. S., Lejbkowicz, F., Kenan, D. J., Chan, E. K., Agol, V. I., Keene, J. D. & Sonenberg, N. (1993). La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol 67, 3798-3807.
48. Mendelsohn, C. L., Wimmer, E. & Racaniello, V. R. (1989). Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56, 855-865.
49. Minor, P. D. (1992). The molecular biology of polio vaccines. J Gen Virol 73, 3065-3077.
50. Nagata, N., Shimizu, H., Ami, Y., Tano, Y., Harashima, A., Suzaki, Y., Sato, Y., Miyamura, T., Sata, T. & Iwasaki, T. (2002). Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol 67, 207-216.
51. Nijhuis, M., van Maarseveen, N., Schuurman, R., Verkuijlen, S., de Vos, M., Hendriksen, K. & van Loon, A. M. (2002). Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR. J Clin Microbiol 40, 3666-3670.
52. Nkowane, B. M., Wassilak, S. G., Orenstein, W. A., Bart, K. J., Schonberger, L. B., Hinman, A. R. & Kew, O. M. (1987). Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA 257, 1335-1340.
53. Pfister, T. & Wimmer, E. (1999). Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. J Biol Chem 274, 6992-7001.
54. Pincus, S. E., Diamond, D. C., Emini, E. A. & Wimmer, E. (1986). Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J Virol 57, 638-646.
55. Pincus, S. E., Rohl, H. & Wimmer, E. (1987). Guanidine-dependent mutants of poliovirus: identification of three classes with different growth requirements. Virology 157, 83-88.
56. Porter, D. C., Ansardi, D. C., Wang, J., McPherson, S., Moldoveanu, Z. & Morrow, C. D. (1998). Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase. Virology 243, 1-11.
57. Ranganathan, S., Singh, S., Poh, C. L. & Chow, V. T. (2002). The hand, foot and mouth disease virus capsid: sequence analysis and prediction of antigenic sites from homology modelling. Appl Bioinformatics 1, 43-52.
58. Ren, R. & Racaniello, V. R. (1992). Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol 66, 296-304.
59. Sabin, A. B. (1965). Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis. JAMA 194, 872-876.
60. Salk, J. E., Bazeley, P. L., Bennett, B. L., Krech, U., Lewis, L. J., Ward, E. N. & Youngner, J. S. (1954). Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation. Am J Public Health Nations Health 44, 994-1009.
61. Sanford, J. R., Gray, N. K., Beckmann, K. & Caceres, J. F. (2004). A novel role for shuttling SR proteins in mRNA translation. Genes Dev 18, 755-768.
62. Shih, S. R., Tsai, M. C., Tseng, S. N., Won, K. F., Shia, K. S., Li, W. T., Chern, J. H., Chen, G. W., Lee, C. C. & other authors (2004). Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob Agents Chemother 48, 3523-3529.
63. Shimizu, H., Agoh, M., Agoh, Y., Yoshida, H., Yoshii, K., Yoneyama, T., Hagiwara, A. & Miyamura, T. (2000). Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives. J Virol 74, 4146-4154.
64. Si, X., Luo, H., Morgan, A., Zhang, J., Wong, J., Yuan, J., Esfandiarei, M., Gao, G., Cheung, C. & McManus, B. M. (2005). Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release. J Virol 79, 13875-13881.
65. Tan, C. S. & Cardosa, M. J. (2007). High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1. Arch Virol 152, 1069-1073.
66. Teterina, N. L., Gorbalenya, A. E., Egger, D., Bienz, K. & Ehrenfeld, E. (1997). Poliovirus protein 2C determinants of membrane binding and rearrangements in mammalian cells. J Virol 71, 8962-8972.
67. Tung, W. S., Bakar, S. A., Sekawi, Z. & Rosli, R. (2007). DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ther 5, 6.
68. Vance, L. M., Moscufo, N., Chow, M. & Heinz, B. A. (1997). Poliovirus 2C region functions during encapsidation of viral RNA. J Virol 71, 8759-8765.
69. Walter, B. L., Nguyen, J. H., Ehrenfeld, E. & Semler, B. L. (1999). Differential utilization of poly(rC) binding protein 2 in translation directed by picornavirus IRES elements. RNA 5, 1570-1585.
70. Wang, S. M., Liu, C. C., Tseng, H. W., Wang, J. R., Huang, C. C., Chen, Y. J., Yang, Y. J., Lin, S. J. & Yeh, T. F. (1999). Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 29, 184-190.
71. Wang, S. M., Lei, H. Y., Huang, K. J., Wu, J. M., Wang, J. R., Yu, C. K., Su, I. J. & Liu, C. C. (2003). Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis 188, 564-570.
72. Wessels, E., Duijsings, D., Niu, T. K., Neumann, S., Oorschot, V. M., de Lange, F., Lanke, K. H., Klumperman, J., Henke, A. & other authors (2006). A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev Cell 11, 191-201.
73. Wu, T. C., Wang, Y. F., Lee, Y. P., Wang, J. R., Liu, C. C., Wang, S. M., Lei, H. Y., Su, I. J. & Yu, C. K. (2007). Immunity to avirulent enterovirus 71 and Coxsackie A16 virus protects against enterovirus 71 infection in mice. J Virol 81, 10310-10315.
74. Yoshikawa, T., Iwasaki, T., Ida-Hosonuma, M., Yoneyama, M., Fujita, T., Horie, H., Miyazawa, M., Abe, S., Simizu, B. & Koike, S. (2006). Role of the alpha/beta interferon response in the acquisition of susceptibility to poliovirus by kidney cells in culture. J Virol 80, 4313-4325.
75. Yu, C. K., Chen, C. C., Chen, C. L., Wang, J. R., Liu, C. C., Yan, J. J. & Su, I. J. (2000). Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 7, 523-528.